## Page 1

Journal of Ethnopharmacology 195 (2017) 10–19
ContentslistsavailableatScienceDirect
Journal of Ethnopharmacology
journal homepage: www.elsevier.com/locate/jep
Review
Mesembrine alkaloids: Review of their occurrence, chemistry, and
MARK
pharmacology
John L. Krstenansky
KGISchoolofPharmacy,535WatsonDr.,Claremont,CA91711,USA
A R T I C L E I N F O A B S T R A C T
Chemicalcompoundsstudiedinthisarticle: Ethnopharmacologicalrelevance: Mesembrinealkaloidsareconsideredtobetheprimaryactiveconstituents
Mesembrine(PubChemCID394162) oftheSouthAfricanmedicinalplantSceletiumtortuosum(L.)N.E.Br.(Aizoaceae),anditisusedasthedriedor
Mesembrenone(PubchemCID216272) fermentedaerialmaterialfromtheplant,whichisknownaskanna(aka,channa,kougoed).Traditionalregional
Mesembrinol(PubChemCID442112) userangedfromrelievingthirst,mildanalgesia,andalterationofmood.Currentinteresthasfocusedprimarily
Sceletenone(PubChemCID102239734)
on the antidepressant action of preparations based on the plant and commercialization is expanding the
Keywords: recognitionandavailabilityofthesepreparations.
Sceletiumtortuosum Materialsandmethods: Searchesforthekeywords“Sceletiumormesembrine”wereperformedin“PubMed-
Alkaloid NCBI”,“ChemicalAbstractsSciFinder”and“ThomsonReutersWebofScience”databasesinadditiontothe
Mesembrine inclusionofreferencescitedwithinpriorreviewsandscientificreports.Additionallythe“SciFinder”database
Mesembrenone
was searched using 3a-phenyl-cis-octahydroindole in the SciFinder Substructure Module (SSM). Plant
Pharmacology
Ethnopharmacology
taxonomywasvalidatedbythedatabase“ThePlantList”.
Results: This review focuses on the chemistry, analysis, and pharmacology of the mesembrine alkaloids.
Despitealonghistoryofmedicinalusedandresearchinvestigation,therehasbeenarenewedinterestinthe
pharmacologicalpropertiesofthemesembrinealkaloidsandmuchofthepharmacologyhasonlyrecentlybeen
published.Thetwomajoractivealkaloidsmesembrineandmesembrenonearestillintheprocessofbeingmore
fullycharacterizedpharmacologically.Theyareserotoninreuptakeinhibitors,whichprovidesarationaleforthe
plant's traditional use as an antidepressant, but other actions are beginning to appear in the literature.
Additionally,mesembrenonehasreasonablypotentPDE4inhibitoryactivity.Thisreviewintendstoprovidean
overviewoftheavailableliterature,summarizethecurrentfindings,andputtheminperspectivewithearlier
studiesandreviews.
1. Introduction Paraphernalia” as “Products that simulate the effects of any illegal
drug”(Amazon.com,2016).Additionally,duetogrowinginterestinthe
Kanna (aka, channa, kougoed) is the dried or fermented aerial useofthisplant,itisnowmostlygrowncommerciallyingreenhouses
materialfromtheplant,Sceletiumtortuosum(L.)N.E.Br(Aizoaceae). and a 2013 study seeking to survey species in the genus for alkaloid
This succulent species is a long-recognized, medicinal plant whose content was unable to source material from the wild and relied on
history and ethnopharmacology has been well reviewed (Gericke and cultivatorsfortheirmaterial(PatnalaandKanfer,2013).Inviewofthe
Viljoen, 2008; Smith et al., 1996). The primary recognized active renewed attention on this plant and the mesembrine alkaloids, the
constituents are a group of mesembrine alkaloids; particularly me- purpose of this review is to update the prior reviews of these area
sembrine(1)andmesembrenone(2)(seeFig.1).Popularinterestin (GerickeandViljoen,2008;Smithetal.,1996)withafocusonrecent
the cognitive and antidepressant actions of kanna (Chiu et al., 2014) analyticalandpharmacologicalreports,andprovideacomprehensive
andproductsbasedonkanna(Terburgetal.,2013)havebeengrowing listingoftheavailableliteraturewithsomecommentaryonkeystudies.
in recent years. Its abuse in combination with cannabis or other Some particularly valuable early reviews of the mesembrine alka-
psychoactive agents has attracted the attention of the US Drug loidsthemselvesoccurwithinacoupleofextensivechemistry-focused
EnforcementAdministration(Dye,2013)andaseizureofthematerial reviewsofSceletiumalkaloids(Jeffs,1981;PopelakandLettenbauer,
was reported as an intelligence alert the DEA's Microgram Bulletin 1967). Mesembrine alkaloids are a subgroup within the Sceletium
(DEA,2008).Interestingly,theretailmarketplace,amazon.com,bans alkaloids.Additionally,anongoingseriesofreviewscoveringliterature
kanna sales and includes it in their list of “Drugs & Drug reports of Amaryllidaceae and Sceletium alkaloids in one to several
E-mailaddress:John_Krstenansky@kgi.edu.
http://dx.doi.org/10.1016/j.jep.2016.12.004
Received12August2016;Receivedinrevisedform6November2016;Accepted5December2016
Available online 07 December 2016
0378-8741/ © 2016 Elsevier Ireland Ltd. All rights reserved.

## Page 2

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
Fig.1.Structuresandidentifyinginformationforthemainmesembrinealkaloidsofcurrentcommercialandpharmacologicalinterest.Thenumberingsystemisshownforthe3a-
phenyl-cis-octahydroindolecorethatischaracteristicofthemesembrinesubgroupofSceletiumalkaloids.Theaverage(MW)andmonoisotopic(ExactMass)molecularweightsaregiven
alongwiththemolecularformulaandChemicalAbstractsService(CAS)numberforeachcompound.
year segments has been published in Natural Product Reports (Jin, “inreview”bytheWorldChecklistofSelectedPlantFamilies(WCSP)
2003, 2005, 2007, 2009, 2011, 2013; Jin et al., 2002; Lewis, 1990, (ThePlantList,2013).Many,butnotallofSceletiumspeciesobtained
1992,1993,1994,1995,1996,1997,1998,1999,2000,2001,2002). from commercial sources, contain mesembrine (Patnala and Kanfer,
2013).ThisfairlyrecentpublicationequatesSceletiumtortuosumwith
2. Occurrenceofmesembrinealkaloids S. joubertii and S. namaquense, which is consistent with Gerbaulet,
1996 despite “The Plant List” considering the former as an accepted
Sceletium is currently the only known genus having species with separate species and the latter as unresolved (Gerbaulet, 1996; The
relatively high levels of mesembrine. Other related plants or other PlantList,2013).Therefore,thisreviewfocusesonthekeyalkaloidsof
genera,suchasNarcissus,containsignificantlysmalleramountsofthe currentpharmacologicalinterestasmuchaspossiblewithoutregardto
alkaloid,ifatall(Berkovetal.,2014;Pignietal.,2013;Smithetal., their source. When alkaloid isolation is discussed, some of the
1998). Early work used the basonym Mesembryanthemum, but the differences in individual alkaloid levels will be noted and the species
genus was abandoned. Earlier publications list species of plant that identification is cited from the paper where available. This review
contain mesembrine or other Sceletium alkaloids; however, some of focuses on the mesembrine subgroup of the Sceletium alkaloids,
thesespecieslistedmaybecurrentlyclassifiedunderdifferentnames characterized by the 3a-phenyl-cis-octahydroindole ring system, be-
(Jeffs,1981;Smithetal.,1996).Forexample,a1967reviewmentions cause they are the subject of the majority of recent commercial and
this genus reclassification and gives four species names as being scientificinterest.Forthesereasons,otherrelatedSceletiumalkaloids
accepted at the time (Popelak and Lettenbauer, 1967). As of 2016 belonging to different subgroups and having different core structures
“ThePlantList”fortheSceletiumgenuscurrentlylists23specieswith thanthoselistedinFig.1,suchasSceletiumA4ortortuosamine,have
19 species accepted (The Plant List, 2013). Of these, Sceletium notbeenincludedinthisreview.
namaquense, a reported mesembrine containing species (Popelak Becauseofthecommercialimportanceofpreparationscontaining
andLettenbauer,1967),isoneofthefourconsideredunresolvedand
mesembrinealkaloids,therehavebeeneffortstodistinguishSceletium
11

## Page 3

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
Table1
CurrentSceletiumspeciesandstatus(ThePlantList,2013).Forstatus,“A”=accepted,moderateconfidencelevel(source:MissouriBotanicalGarden,Tropicos);“U”=unresolved,low
confidencelevel(WCSP(inreview).Mesembrinepresenceasreportedintheliteraturewithreferencegivenorreferencewhereitwasnotdetected.Ifmultiplereferencesciteitspresence,
thena“+”isaddedafterthecitation.
Name Status Mesembrine Reference
SceletiumalbanenseL.Bolus A Yes–possible Footnote1
SceletiumanatomicumL.Bolus A Yes–confirmed RimingtonandRoets,1937 +
SceletiumarcheriL.Bolus A No–possible Footnote2
SceletiumborealeL.Bolus A Yes–possible Footnote3
SceletiumcompactumL.Bolus A Yes–possible Footnote3
SceletiumconcavumSchwantes A Yes–possible Footnote3
SceletiumcrassicauleL.Bolus A Yes–confirmed Shikangaetal.,2013
SceletiumdejageraeL.Bolus A No–possible Footnote4
SceletiumemarcidumL.Bolus A No–confirmed PatnalaandKanfer,2013
SceletiumexalatumGerbaulet U No–confirmed PatnalaandKanfer,2013
SceletiumexpansumL.Bolus A Yes–confirmed HartwichandZwicky,1914 +
SceletiumframesiiL.Bolus A Yes–possible Footnote3
SceletiumgracileL.Bolus A Yes–possible Footnote3
SceletiumjoubertiiL.Bolus A No–confirmed ArndtandKruger,1970
SceletiumnamaquenseL.Bolus U Yes–confirmed PopelakandLettenbauer,1967 +
SceletiumovatumL.Bolus A Yes–possible Footnote3
SceletiumregiumL.Bolus A Yes–possible Footnote5
SceletiumrigidumL.Bolus A No–confirmed PatnalaandKanfer,2013
SceletiumstrictumL.Bolus A Yes–confirmed Jeffsetal.,1971 +
SceletiumsubvelutinumL.Bolus U No–confirmed HerbertandKattah,1990
Sceletiumtortuosum(L.)N.E.Br. A Yes–confirmed HartwichandZwicky,1914 +
SceletiumtugwelliaeL.Bolus A Yes–possible Footnote3
SceletiumvariansL.Bolus A No–possible Footnote6
Table1Footnotes:1:≡S.crassicaule(Haw.)L.Bolus(Gerbaulet,1996)indicatingthepossiblepresenceofmesembrine;2:≡S.rigidumL.Bolus(Gerbaulet,1996)indicatingapossible
lackofmesembrine;3:≡S.tortuosum(L.)N.E.Br.(Gerbaulet,1996)indicatingthepossiblepresenceofmesembrine;4:≡S.emarcidum(Thunb.)L.BolusexH.J.Jacobsen(Gerbaulet,
1996)indicatingapossiblelackofmesembrine;5:≡S.expasum(L.)L.Bolus(Gerbaulet,1996)indicatingthepossiblepresenceofmesembrine;6:Sceletiumvarians(Haw.)Gerbaulet
comb.nov.≡Sceletiumsubvelutinum(L.)Bolusformasubvelutinum(Gerbaulet,1996)indicatingapossiblelackofmesembrine.
speciesbyimagingtechniques(Shikangaetal.,2013)andtoquantify stereochemistry within any source. The structures depicted in this
thealkaloidcomponentswithinsamplesfromcommercialpreparations reviewreflectthestereochemistryasestablishedbyJeffs’studiesnoted
ofSceletiumtortuosum(Shikangaetal.,2012a,2012b,2012c). above.
Table1liststhecurrent23speciesfrom“ThePlantList”indicating
thecurrentstatusoftheirclassification.Theearliestreferenceforthe 3.1.1. Mesembrine (1): (3aS,7aS)-3a-(3,4-dimethoxyphenyl)-1-
identificationofmesembrineinaparticularspeciesisgiven.Ifaspecies methylhexahydro-1H-indol-6(2H)-one
had been evaluated, but mesembrine had not been detected in Thisalkaloidisthemoststudiedofthemesembrinealkaloidsdueto
significant amounts, then this is indicated as “No – confirmed”. itsrelativeabundanceinSceletiumtortuosumandbiologicalactivity.
Nevertheless,inthesecases,othermesembrinealkaloidsweretypically Mesembrinewasinitiallypartiallyisolated,characterized,andnamed
present (Patnala and Kanfer, 2013). Species lacking a reference have by Zwicky (Hartwich and Zwicky, 1914; Zwicky, 1915). Following on
not been evaluated in the literature reviewed so the presence of that report, mesembrine was purified and crystallized as the picrate
mesembrine is uncertain. Footnotes in the table point to species (mp193–194°C)andtheplatinichloride(mp181°C)(Rimingtonand
equivalencies based on Gerbaulet, 1996, which may indicate the Roets, 1937). They also reported some color tests performed on the
liklihood of the presence of mesembrine for species not otherwise non-crystallinehydrochloridesalt.
cited in the literature as having been examined for the presence of In 1957, mesembrine was isolated and crystallized as the hydro-
mesembrine and mesembrine alkaloids (Gerbaulet, 1996). The basis chloridesaltfromisopropanol-ethanol(mp199–201°C)andreported
fordrawingthesetentativeconclusionsstemsfromthealkaloidpatters the IR spectrum (Bodendorf and Krieger, 1957). They correctly
observedforthespeciessubsetswithinSceletium(PatnalaandKanfer, identifiedthatthematerialcontainedtwomethoxygroupsandanN-
2013).Thus,it canbeseenthat mesembrineis presentinmany, but methylgroup,correctingearlierreportsclaimingmesembrinetobea
notallspeciesoftheSceletiumgenus.Fromacommercialstandpoint, phenolicbase,whichitisnot.
studiesdirectedatthevariabilityofmesembrinealkaloidcomposition In 1960, Popelak, et al. correctly reported the structure of me-
withregardtospecies,strain,timeofharvest,andgrowingconditions sembrine, physical data, and characterized a variety of derivatives
wouldbeofgreatimportance. throughchemicalmodificationoftheisolatedalkaloid(Popelaketal.,
1960a, 1960b). It should be noted that mesembrine HCl can be
3. Chemistry recrystallizedfrom2-propanol;however,attemptsatcrystallizingthis
saltfromethanolproducesanethylenoletherfromtheketogroupthat
3.1. Structureandproperties canbeconvertedbacktomesembrineHClbytreatmentwith0.1Naq.
HCl. Enol formation does not occur with the free base in ethanol
The absolute stereochemistry for the mesembrine alkaloids as (PopelakandLettenbauer,1967).
shown in Fig. 1 was established by x-ray crystallography of 6-
epimesembranol methiodide and later that of (-)-mesembrine HCl
(Cappsetal.,1977;Coggonetal.,1970).Itwasinagreementwiththe Lit.(PopelakandLettenbauer,1967)
assignmentofstereochemistryofmesembrinebasedonCDandNMR mesembrine(freebase) [α] 20 =−55°(MeOH)bp 138°C
studies(Jeffsetal.,1969).Itshouldbenotedthatanumberofpapers D 0.05
andinternetsourcesdepictincorrectstereochemistryforsomeofthe mesembrineHCl [α] 20 =−8.4°(MeOH)mp205–
D
alkaloids,soitisimportanttocarefullynoteandestablishthecorrect
12

## Page 4

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
206°C
Lit.(TaberandHe,2005) Lit.(PopelakandLettenbauer,1967)
mesembrine,colorless [α] 20 =−55.4°(c0.54,MeOH); Mesembrinol [α]=−32°(CHCl 3 ); mp144–145°C
oil D Lit.(Chidaetal.,1994)
IR(neat,cm−1):2944(m),1716(s),1520(s),1454(m),1253(s), Mesembrinol [α]=−28°(c0.2,CHCl
3
); mp146–147°C
1148(m),1027(m);
1HNMR(400MHz,CDCl )δ:6.93(dd,J=8.4,2.4Hz,1H),
3
6.90(d,J=2.0Hz,1H),6.84(d,J=8.4Hz,1H),3.90(s,3H),
3.88(s,3H),3.13–3.17(m,1H),2.96(t,J=3.6Hz,1H),2.61 3.1.4. mesembrenol (5): (3aR,6S,7aS)-3a-(3,4-dimethoxyphenyl)-1-
(m,2H),2.35–2.46(m,2H),2.33(s,3H),2.04–2.26(m,5H); methyl-2,3,3a,6,7,7a-hexahydro-1H-indol-6-ol
13CNMR(CDCl ,90MHz)δu:211.5,149.3,147.8,140.4,55.1,
Jeffs,etal.firstisolated,crystallized,andidentifiedthisalkaloidin
3
1970asthemajoralkaloidcomponentofSceletiumstrictum(L.)Bolus
47.8,40.8,39.1,36.4,35.5;d:118.2,111.3,110.3,70.6,56.2,
(Aizoaceae) (Jeffs et al., 1970). The material used in this study had
56.1,40.3
been grown from seed in a greenhouse for three years and was
Racemicmesembrine,whichis theproductofseveraltotalsynth- identified by L. Bolus, Bolus Herbarium, University of Cape Town,
esis routes (Chavan et al., 2004; Gelas-Mialhe et al., 1992; Gramain SouthAfrica.
and Remuson, 1985; Hackett and Livinghouse, 1986; Honda et al.,
2012; Hoshino et al., 1978, 1987; Jeffs et al., 1983; Kochhar and
Pinnick,1983;Kulkarnietal.,2002;Martinetal.,1979;Michaeletal., Lit.(Jeffsetal.,1970)
1992; Ohishi and Kugita, 1968, 1970; Parkinson and Pinhey, 1991; Mesembrenol [α]=+91°(c mp140°C(recrys.from
Rajagopalan,1997;RigbyandDong,2000;Roeetal.,2008;Shamma 0.0176,CHCl 3 ) EtOAc)
and Rodriguez, 1965, 1968; Shono et al., 1989; Spittler et al., 2016; mp122–124.5°C(recrys.
Stevens et al., 1975; Takano et al., 1981a; Zhao et al., 2009), can be fromacetone)
resolvedtothenaturall-isomerthroughfractionalcrystallizationusing 1HNMR(100MHz)δ:6.84(m,3H,ArH),5.70(qoft,J 4,5 =
α-bromo-D-camphor-π-sulfonicacid(PopelakandLettenbauer,1962). 10.5Hz,J
4,6
=1.8Hz,J
5,6
=J
5,7a
=J
4,7a
=1.5Hz,2H,-CH=CH-
),
4.30(m,1H,C6H),3.76(s,3H,–OCH ),3.80(s,3H,-OCH ),
3.1.2. Mesembrenone (2): (3aR,7aS)-3a-(3,4-dimethoxyphenyl)-1- 3 3
2.30(s,3H,NCH ).
methyl-3,3a,7,7a-tetrahydro-1H-indol-6(2H)-one 3
Thematerialreadilyracemizes(e.g.,ethanolicsolutionfor17hat
25°C or 5min at 50°C) via acid or base catalyzed reversible β-
eliminationto9(Fig.2)(Jeffsetal.,1970).
3.2. Biosynthesis
Lit.(Jeffsetal.,1970) ThebiosyntheticpathwaydepictedinFig.3,suggestedbythework
Mesembrenone, CD[θ] 0°,[θ] −4060°,[θ] 0°(c involvingradiolabeledprecursormaterials,proposesthatthearomatic
395 334 310 groupofmesembrinecomesfromphenylalanineandtheperhydroin-
anoil 1.072mg/mL,ethanol)
Mesembrenone mp204–207°C dole portion comes from tyrosine (Jeffs et al., 1971). From phenyla-
lanine, cinnamic acid intermediates are produced, but the 3′-aryl
HCl
oxygen substituentis introducedlate inthe pathwayasevidenced by
thelatestepsinvolvingsceletenone(CAS51934-31-7),4′O-demethyl-
mesembrenone,andmesembrenone(Jeffsetal.,1978).
3.1.3. mesembrinol; mesembranol (4): (3aS,6R,7aS)−3a-(3,4-
dimethoxyphenyl)−1-methyloctahydro-1H-indol-6-ol 3.3. Isolation
Muchofthehistoricalliteratureusesthemesembranolname.This
alkaloiddiffersfromepimesembranol(7)onlyinthestereochemistry Many alkaloid isolations using varied techniques and different
atthe6positionalcohol.Itcanbeseparatedfromitsepi-counterpart speciesofplanthavebeenreported(ArndtandKruger,1970;Bastida
by crystallization, since the epi-form does not crystallize, or by et al., 1989; Doepke et al., 1981; Jeffs et al., 1970, 1982; Jeffs and
chromatography(PopelakandLettenbauer,1967). Capps, 1979; Nieuwenhuis et al., 1981; Rimington and Roets, 1937;
Fig.2.Racemizationofmesembrenoneviareversibleβ-elimination(Jeffsetal.,1970).
13

## Page 5

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
Fig.3.Proposedbiosyntheticpathway(Jeffs,1981).Somearrowsrepresentmorethanonestepinthepathway.
Shikangaetal.,2011).Acoupleofexamplesarepresentedbelowwith ing materials were obtained from the fractions in the following
the isolated yield from each. Note that the isolated yield is not only amounts: mesembrine (1) 0.067%; mesembrenone (2) 0.025%; me-
dependentontheefficientlyofthemethod,butalsoontheabundance sembranol (4) 0.058%; mesembrenol (5) 0.71%; (See Fig. 1 for
ofthealkaloidsinthestartingplantmaterialused. structures). Note that the major alkaloid from this plant species was
mesembrenol.
3.3.1. Alcoholextractionwithneutralaluminacolumn
Fresh 3 year old plants of Sceletium strictum were homogenized 3.3.2. Highperformancecountercurrentchromatography(HPCCC)
with95%ethanol,heatedandfiltered(Jeffsetal.,1971).Thematerial Anisolationprocessthatstartedwithanacidextractionofthedried
usedinthisstudyhadbeengrownfromseedinagreenhouseforthree Sceletiumtortuosummaterialgiving1.9%byweightofcrudealkaloid
years and wasidentified by L. Bolus, Bolus Herbarium,University of extracthasbeenreported(Shikangaetal.,2011).Thisplantmaterial
CapeTown,SouthAfrica.ThesolidwasfurtherSoxhletextractedwith usedinthestudywascollectedinApril2009fromtheWesternCape
methanol. The combined extracts were concentrated, treated with South Africa with a voucher specimen kept at the Dept. of
sodium carbonate and extracted with chloroform. Evaporation of the Pharmaceutical Sciences, Tshwane University of Technology. This
chloroform left the crude alkaloid (2.5% w/w). The crude alkaloid wasfractionatedonasilicagelcolumntogiveonefractioncontaining
fractionwaselutedonneutralaluminacolumnusingalineargradient alkaloids 1 and 2 and another fraction containing 4 and 5. Using a
of benzene against ethyl acetate followed by ethyl acetate/methanol high-performance countercurrent chromatography instrument on the
andfinallymethanol.FractionswereanalysedbyGC-FID.Thefollow- twofractions,theyobtainedeachofthefouralkaloidsin >95%purity.
14

## Page 6

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
Theoverallisolatedamountsfromdriedplantmaterialwere10.21%; 3.5. Totalsynthesis
20.24%;40.025%;50.16%.
Asearlyas1962,asyntheticrouteformesembrineandmesembrine
3.4. Analysis analogs was patented (Popelak and Lettenbauer, 1962). Since then,
numerous total syntheses of both the racemic (Chavan et al., 2004;
Both preclinical, clinical, and forensic study of mesembrine alka- Gelas-Mialheetal.,1992;GramainandRemuson,1985;Hackettand
loid-containing products requires sensitive validated assays for the Livinghouse, 1986; Honda et al., 2012; Hoshino et al., 1978, 1987;
qualitativeandquantitativeanalysisofthosealkaloidsorthemetabo- Jeffs et al., 1983; Kochhar and Pinnick, 1983; Kulkarni et al., 2002;
lites. The recent literatureprovides a variety of such methods, which Martin et al., 1979; Michael et al., 1992; Ohishi and Kugita, 1968,
greatlyenableabroadrangefuturestudies. 1970; Parkinson and Pinhey, 1991; Rajagopalan, 1997; Rigby and
Dong, 2000; Roe et al., 2008; Shamma and Rodriguez, 1965, 1968;
3.4.1. High performance thin layer chromatography (HPTLC)- Shono etal., 1989; Spittleret al., 2016; Stevens et al., 1975;Takano
densitometry et al., 1981a; Zhao et al., 2009) and both individual stereoisomers
HPTLCisarobustmethodfortheanalysisandcharacterizationof (Arns et al., 2007; Dalko et al., 1998; Denmark and Marcin, 1997;
botanical products (Toniolo et al., 2014). Using Silica gel 60 F254 Geoghegan and Evans, 2013; Ilardi et al., 2009; Kosugi et al., 1993;
HPTLCplateselutedwithdichloromethane–methanol–10%ammonia Meyers et al., 1985; Mori et al., 1997a, 1997b; Nemoto et al., 1994,
(90:10:0.1,v/v)(Shikangaetal.,2012b).Densitometricquantification 1995; Nunokawa et al., 2015; Otani and Yamada, 1973; Ozaki and
wasbasedonabsorbanceat280nm.LimitofDetection(LOD)wasin Kobayashi, 2015; Paul et al., 2006; Taber and Neubert, 2001; Taber
the range of18–31ngper band andlimit of quantitation(LOQ) was andHe,2005;Takanoetal.,1981b,1990;YamadaandOtani,1971;
44–95ng per band for the four main mesembrine alkaloids. The Yokomatsuetal.,1992;YoshimitsuandOgasawara,1996;Zhangetal.,
validated method was reported useful for raw plant material and 2012)havebeenreportedandmuchofthisworkhasbeenpresentedin
commercialproductscontainingSceletiumtortuosumalkaloids. a Japanese review covering 31 published routes (Zhao et al., 2010).
WhilethepaperisinJapanese,whichpresentsabarrierforthosewho
3.4.2. Capillaryelectrophoresismethods(CE) cannottranslatethearticle,themanysyntheticschemesareinEnglish
Anonaqueouscapillaryelectrophoresis-massspectrometry(NACE- and having them together in one reference is valuable. Despite these
MS)methodforforensicanalysisofSceletium-containingproductsand extensivesyntheticeffortsand theavailability ofcommerciallygrown
toanalyzeproductsthefermentation processofSceletium tortuosum Sceletium tortuosum there is currently no commercially available
hasbeenreported(Roscheretal.,2012).Thespecies-identifiedplant source for the mesembrine alkaloids in pure form. Commercial
materials used in this study were obtained from two commercial availability of pure materials at a reasonable price would be of
sources. The method, originally developed for the analysis of kratom considerable value enabling pharmacologists worldwide to expand
alkaloids, has a mean dynamic range is 0.1–500μM, based on ourunderstandingofthesematerials.
Harmalaalkaloidstandards. The total synthesis of analogs based on a mesembrine core
A capillary zone electrophoresis method for the analysis of me- structurereportedmodestanalgesicactivityinamousehotplatetest
sembrineinSceletiumtortuosumproductshasbeenreportedwithan foroneoftheanalogs,3-((3aS,7aS)-1-methyloctahydro-3aH-indol-3a-
LOQandLODof2.5and1.5μg/mL,respectively(PatnalaandKanfer, yl)phenol(Langloisetal.,1971,1972).
2008). Biovitrum submitted a patent application covering substituted
mesembrine analogs as melanin concentrating hormone receptor
3.4.3. Gaschromatography-massspectrometry(GC-MS) (MCH1R) antagonists for the modulation of appetite (Browning
GC-MScombinedwithothermethodshavebeenusedtoprovidea et al., 2005). They present a total synthesis of a large number of
detailedmetabolicanalysisofthemesembrinealkaloidsfromraturine analogs.Example70intheapplicationisa6-substitutedmesembrine
(Meyer et al., 2015), and GC-MS alone has been used to develop a analog with a p-trifluoromethoxyphenylurea group having a K of
i
methodthathasaLODof12–23μg/mLandLOQof35–68μg/mLfor 52nMattheMCH1R.
thefourmainmesembrinealkaloids.
4. Biology
3.4.4. Highperformanceliquidchromatography(HPLC)
AlongwiththeGC-MSmethod,amoresensitivereversephase-ultra 4.1. Metabolism
high performance liquid chromatography-photodiode array (RP-
UHPLC-PDA) method was developed with a LOD of 0.9–1.2μg/mL Themetabolismofisolatedandpurifiedmesembrineandmesem-
andLOQof2.7–3.7μg/mL(Shikangaetal.,2012a).AsensitiveHPLC brenoneinvivointherat,andinvitrousingahumanliverpreparation
methodhasbeenpublishedthatislinearintheconcentrationrangeof hasbeenreported(Meyeretal.,2015).O-andN-demethylationswere
0.4–60mg/mL with a LOD of 100ng/mL and a LOQ of 200ng/mL observed for both alkaloids. Reduction (dihydro metabolite) was
(PatnalaandKanfer,2010).Finally,liquidchromatography-linearion observed and hydroxylation was observed at different positions. The
trap high resolution mass spectrometry (LC-HR-MSn) was used as a resultingphenolicmetaboliteswerepartlyexcretedasglucuronidesor
component of metabolism studies discussed in more detail below sulfates. For mesembrine the most abundant metabolites were the
(Meyeretal.,2015). acetylateddemethyl-dihydroandhydroxymetabolitesinraturine.For
mesembrenone the demethyl-dihydro were the most abundant meta-
3.4.5. Direct analysis in real time ionization coupled with high bolitesintheraturine.
resolutiontime-of-flightmassspectrometry(DARTHRTOFMS)
ForensicanalysisofkannafromavarietyofsuppliersusingDART- 4.2. Pharmacology
HRTOFMSwasperformedinordertoassessthepresenceoftheplant
materials as well as adulterants (Lesiak et al., 2016). Using five Despitethelonghistoryofthemedicinalactionsofkannaandthe
different samples, the major alkaloids were identified, providing depthoftheliteratureonisolationandtotalsynthesisofmesembrine
evidenceforthepresenceoftheadvertisedplantmaterial,andinone andrelatedalkaloids,therehasbeensurprisinglylittlepublishedonthe
case,adulterationwithabannedchemicalwasidentified,establishing pharmacologyoftheindividualalkaloids,whichislikelypartlydueto
this method as useful in identifying misrepresented and potentially thelackofcommerciallyavailablepurealkaloids.Nonetheless,asmore
unsafeproducts. is learned about the pharmacology of these materials the number of
15

## Page 7

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
patentsandapplicationsfortheuseofmesembrinealkaloidprepara- 4.2.5. CB1receptorbinding
tionshasbeengainingpace(Davies,2016;Gerickeetal.,2015,2016; Mesembrinehasbeenshowntobindtoclonedhumancannabinoid
Gericke and Van Wyk, 2001; Harvey et al., 2010; Holford, 2002). A CB1 receptors in vitro with about 1% the potency of the Δ9-tetrahy-
report of three clinical cases using Sceletium tortuosum tablets has drocannabinol (THC) standard (Lubbe et al., 2010). Due to the low
previously been reviewed pointing to potential therapeutic utility of potency, a binding constant was not determined. This result was in
such a preparation (Gericke and Viljoen, 2008). Controlled human agreementwithalaterreceptorscreeningstudy(Harveyetal.,2011).
trialsmentionedbelowarebeginningtoappearandarethefirststepin
providingevidenceforwideacceptanceanduseofthesematerials. 4.2.6. Inhibitionofforskolin-inducedsteroidogenesis
Aninvitrostudyexaminingtheabilityofhighmesembrine-content
standardized extract, Trimesemine™, to affect steroidogenesis using
4.2.1. Receptorscreening
the human adrenocortical carcinoma cell line H295R was reported
In 2011, an attempt at a comprehensive pharmacological screen,
(SwartandSmith,2016).TheTrimesemine™preparationisalyophi-
beganwithacommercialmaterial,Zembrin®,whichisastandardized
lizedextractpreparedfromaproprietaryhybrid(DV17)ofS.tortuo-
extractofSceletiumtortuosum(Harveyetal.,2011).Thepreparation
sum (L.) N.E. Br. and S. expansum (L.) L. Bolus (Aizoaceae) using a
consists of 0.35–0.45% total alkaloids, with mesembrenone and
proprietarymethod,consistsprimarilyofmesembrine(1),Δ7-mesem-
mesembrenol comprising ≥60%, and mesembrine contributing <
brenone (3), and mesembrenone (2), as demonstrated by UPLC-MS
20% (Murbach et al., 2014). This mixture was screened in 77
(seeFig.1forstructures).TheresultsdemonstratethatTrimesemine™
radioligand binding assays at 0.75mg/mL and a panel of phosopo-
affects steroid hormone production, possibly through modulation of
diesterases.Theextractgave >80%inhibitionatGABAreceptors(non-
thecatalyticactivityofsteroidogenicenzymes.
selective),serotonin(5-HT)transporter,δ -andμ-opioidreceptors,the
2
cholecystokinin-1 receptor, and PDEs 3 and 4 (Harvey et al., 2011).
4.2.7. Mouseforcedswimtest
Followingupontheseresults,thepotencyoftheisolatedalkaloidsat
In 2014 Schell reported a study comparing a partially purified
the 5-HT transporter and with PDE4 were reported, as described
alkaloid extract containing the main mesembrine alkaloids to parox-
separatelyinthefollowingSections4.2.2and4.2.3.
etine in a mouse forced swim test, a rodent model for depression
(Schell, 2014). The relative composition of the alkaloid mixture used
4.2.2. Serotoninreuptakeinhibition wasmesembrine9.2%,mesembrenone8.0%,mesembrinol67.0%,and
Individual alkaloids isolated from Sceletium tortuosum extract mesembrenol15.8%asdeterminedbyGC/MS.At10and80mg/kgi.p.
were tested against the 5-HT transporter (SERT) and the Ks for doseofthealkaloidmixturewascomparedwitha1mg/kgi.p.doseof
i
mesembrine, mesembrenone, and mesembrenol were 1.4, 27, and paroxetine, which was calculated to give a comparable level of
63nM,respectively(Harveyetal.,2011).Thesevaluesarecomparable serotonin reuptake inhibition based on the literature IC s for me-
50
to the marketed SSRI, fluoxetine (Tavoulari et al., 2009) and signifi- sembrinevsparoxetine.Boththealkaloidmixtureandparoxetinehad
cantly more potent than values seen for related Amaryllidaceae comparable activity in this depression model, while neither demon-
alkaloids, such as buphanidrine or distichamine with SERT Ks of stratedanylocomotoreffectsatthesamedoselevels.
i
312 and 868μM, respectively, which derive from another traditional
anxietytreatingplantBoophonedisticha(L.f.)Herb(Amaryllidaceae) 4.2.8. Humantrials
(Sandageretal.,2005). Since 2009, the aforementioned preparation Zembrin® has been
studiedforsafetyandcognitiveeffectsinanumberofhumantrials.
The first report was a double-blind, placebo-controlled study
4.2.3. PDE4inhibition
performed in 2009 that examined the safety and tolerability at
The isolated alkaloids mesembrine, mesembrenone, and mesem-
dosesof8mgand25mgoncedailyoverathreemonthperiod(Nell
brenol inhibited PDE4B with IC s of 7.8, 0.47, and 16μM, respec-
50 etal.,2013).Adozenhealthyadultswereusedineacharmofthe
tively(Harveyetal.,2011).TheprotypicalPDE4inhibitorrolipramis
studyandcomparedtothirteensubjectsreceivingplacebo(18–55
at least 3-times more potent with an IC for PDE4B of 0.13μM
50 years of age). Both doses were well tolerated and adverse effects
(MacKenzieandHouslay,2000).Relatedtothismechanismofaction,
were the same as or less frequent than was seen for the placebo
one in vivo study correlated the responses seen by Zembrin® extract
group.
and rolipram as interpreted as an electopharmacogram, which is a
Another double-blind, placebo-controlled cross-over design study
frequency analysis of the field potentials recorded from the frontal
in sixteen healthy undergraduate students (18–21 years) used func-
cortex,hippocampus,striatumandreticularformationinthepresence
tionalmagneticresonanceimaging(fMRI)2hafterasingle25mgdose
ofdrugsinfreelymovingrats(Dimpfeletal.,2016b).
ofZembrin®orplacebofocusingonamygdalaactivityinresponsetoan
Since the identification of PDE inhibition for these alkaloids, a
anxiety-related activity and amygdala-hypothalamus coupling in an
numberofpatents,whereaPDEinhibitorwouldhaveutilityaloneorin
emotion matching task (Terburg et al., 2013). There results were
combination with other substances, have included the mesembrine
interpreted as demonstrating anxiolytic potential consistent with the
alkaloids among a list of other PDE inhibitors (Collins et al., 2014;
previously proposed serotonin reuptake inhibition (SRI) and PDE4
Hammocketal.,2011;Kielian,2014;LefebvreandDeMaeyer,2013).
inhibitory activity (Harvey et al., 2011); however, there were no
positivecontrolstoassesstherelativeeffectsversusestablishedcontrol
4.2.4. IncreasedVAMT-2expression SRIsorPDE4inhibitors.
The effects of a high mesembrine-content standardized extract, A randomized double-blind, placebo-controlled, cross-over design
Trimesemine™, (3% mesembrine (w/w)) on human astrocytes and clinical trial using 25mg capsules of Zembrin® in 21 cognitively
mouse hippocampal cells in comparison to the effect elicited by the healthysubjectswasreported(Chiuetal.,2014).Thedosingwasonce
racemic mixture SSRI, citalopram (Coetzee et al., 2016). The me- daily for 3 weeks. Zembrin® was well tolerated and demonstrated
sembrine extract caused less down-regulation of expression of SERT improvedexecutivefunctionalongwithpositivechangesinmoodand
than citalopram and a greater upregulation of expression of the sleep.
vesicular monoaminetransporter-2 (VAMT-2) than citalopram. These Recently, a larger double-blind, randomized, placebo-controlled
results were interpreted by the authors as meaning that the primary study in 60 healthy adults (40–75 years) was conducted using 25 or
mechanismofactionofthisextractisthroughmonoaminereleaseand 50mg doses of GMP-manufactured Zembrin® versus placebo using
thatserotoninreuptakeinhibitionissecondarytothisreleaseeffect. quantitative17-channelEEGandeye-tracking,twohoursafterdosing,
16

## Page 8

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
while being challenged cognitively and emotionally (Dimpfel et al., References
2016a). Psychometric performance improvement suggest a small
improvement versus placebo, but the results were not statistically Amazon.com,2016.SellingatAmazon.com:Drugs & DrugParaphernalia:Examplesof
significant.Mostsignificantwasthedocumentationofconsistent,dose- ProhibitedListings.〈http://www.amazon.com/gp/help/customer/display.html/?
NodeId=200277220〉(accessed16.11.02).
relatedchangesinbrainactivitythatcouldserveasabaselineforfuture
Arndt,R.R.,Kruger,P.E.J.,1970.AlkaloidsfromSceletiumjoubertii.Structureof
studies. joubertiamine,dihydrojoubertiamine,anddehydrojoubertiamine.TetrahedronLett.
In summary, these studies appear to give good evidence to safety 37,3237–3240.
Arns,S.,Lebrun,M.-E.,Grise,C.M.,Denissova,I.,Barriault,L.,2007.Diastereoselective
and tolerability in healthy subjects at the doses tested and over the
constructionofquaternarycarbonsdirectedviamacrocyclicringconformation:
periodoftimeofthestudies;however,themodestsizeofthestudies, formalsynthesisof(-)-mesembrine.J.Org.Chem.72(24),9314–9322.
lackofpositivecontrolslimittheconclusionsthatcanbedrawnabout Bastida,J.,Viladomat,F.,Llabres,J.M.,Ramirez,G.,Codina,C.,Rubiralta,M.,1989.
thetherapeuticutilityoftheagents. Narcissusalkaloids.VIII.Mesembrenone:anunexpectedalkaloidfromNarcissus
pallidulus.J.Nat.Prod.52(3),478–480.
Berkov,S.,Martinez-Frances,V.,Bastida,J.,Codina,C.,Rios,S.,2014.Evolutionof
alkaloidbiosynthesisinthegenusNarcissusPhytochemistry99.Elsevier,95–106.
4.3. Toxicology Bodendorf,L.K.,Krieger,W.,1957.AlkaloidsofMesembryanthemumtortuosum.Archiv
der.Pharm.undBer.derDtsch.Pharm.Ges.290,441–448.
A toxicological study of Zembrin® in male and female rats was Browning,A.,Nilsson,J.,Scobie,M.,Angbrant,J.,Ringom,R.,2005.NewCompounds.
Biovitrum,USPatentApplication2005/0239841.
reported (Murbach et al., 2014). No mortality or treatment-related Capps,T.M.,Hargrave,K.D.,Jeffs,P.W.,McPhail,A.T.,1977.Sceletiumalkaloids.Part7.
adverseeffectsinthe14-or90-daystudiesatdosesrangingfrom100 Structureandabsolutestereochemistryof(-)-mesembraneand3′-methoxy-4′-O-
methyljoubertiamine,twominorbasesfromS.namaquenseL.Bolus:x-rayanalysis
to5000mg/kgbw/day.
of(-)-mesembranehydrochloridemonohydrate.J.Chem.Soc.,PerkinTrans.2:
Phys.Org.Chem.1972–1999(8),1098–1104.
Cashman,J.R.,Ghirmai,S.,2009.Inhibitionofserotoninandnorepinephrinereuptake
5. Conclusions andinhibitionofphosphodiesterasebymulti-targetinhibitorsaspotentialagentsfor
depression.Bioorg.Med.Chem.17(19),6890–6897.
Cashman,J.R.,Voelker,T.,Johnson,R.,Janowsky,A.,2009a.Stereoselectiveinhibition
While the pharmacology and mechanism(s) of action for the
ofserotoninre-uptakeandphosphodiesterasebydualinhibitorsaspotentialagents
behavioral effects of the individual mesembrine alkaloids and fordepression.Bioorg.Med.Chem.17(1),337–343.
preparationscontainingmixturesofthese alkaloids isnotentirely Cashman,J.R.,Voelker,T.,Zhang,H.T.,O'Donnell,J.M.,2009b.Dualinhibitorsof
phosphodiesterase-4andserotoninreuptake.J.Med.Chem.52(6),1530–1539.
clear, it is evident from in vitro, in vivo, and clinical studies that Chavan,S.P.,Khobragade,D.A.,Pathak,A.B.,Kalkote,U.R.,2004.Asimpleandefficient
the main mesembrine alkaloids are bioavailable CNS-active mate- synthesisof(±)-mesembrine.TetrahedronLett.45(27),5263–5265.
rials worthy of further study. One current limitation is the lack of Chida,N.,Sugihara,K.,Ogawa,S.,1994.Chiralsynthesisof(-)-mesembranolstarting
fromD-glucose.J.Chem.Soc.,Chem.Commun.7,901–902.
commercially available pure substance and reference materials.
Chiu,S.,Cernovsky,Z.,Gericke,N.,Farina-Woodbury,M.,Antongiorgi,J.,Badmaev,V.,
Despite the broad screening of an mesembrine alkaloid mixture Raheb,H.,Terpstra,K.,Bureau,Y.,Hou,J.,Sanchez,V.,Williams,M.,Goble,L.,
followed by testing of the individual alkaloids against the positive Copen,J.,Husni,M.,2014.Proof-of-conceptrandomizedcontrolledstudyof
hitsfromthemixture(Harveyetal.,2011),itwouldstillbeofvalue
cognitioneffectsoftheproprietaryextractSceletiumtortuosum(Zembrin®)
targetingphosphodiesterase-4incognitivelyhealthysubjects:implicationsfor
to broadly screen (affinity and functionality) the individual alka- Alzheimer'sdementia.Evid.-BasedComplement.Altern.Med.:eCAM2014,682014.
loidstobetterunderstandtheirfunctionalactivityandselectivityin Coetzee,D.D.,Lopez,V.,Smith,C.,2016.High-mesembrineSceletiumextract
addition to their potency. Seldom are CNS drugs completely
(Trimesemine™)isamonoaminereleasingagent,ratherthanonlyaselective
serotoninreuptakeinhibitor.J.Ethnopharmacol.177,111–116.
selective for one target. From the standpoint of developing these Coggon,P.,Farrier,D.S.,Jeffs,P.W.,McPhail,A.T.,1970.Absoluteconfigurationof
materials or their analogs into therapeutic agents, considerably mesembrineandrelatedalkaloids:x-rayanalysisof6-epimesembranolmethiodide.
more study is needed concerning the ultimate safety of these
J.Chem.Soc.[Sect.]B:Phys.Org.7,1267–1271.
Collins,J.J.,Belenky,P.A.,Camacho,D.M.,2014.Compositionsandmethodsfor
alkaloids and alkaloid mixtures. Additionally a competitive threat
treatingfungalinfections.TrusteesofBostonUniversity,(PCTApplication
existsfromnon-mesembrinecompoundsthatselectforthesameor WO2014130922).
multiple CNS targets, such as the dual serotonin reuptake inhibi- Dalko,P.I.,Brun,V.,Langlois,Y.,1998.Aconcisesynthesisof(-)-mesembrine.
TetrahedronLett.39(49),8979–8982.
tors having PDE4 inhibitory activity that have been reported
Davies,R.P.,2016.Stabilizedmesembrinecompositions.BotanicalResourceHoldings
(CashmanandGhirmai,2009;Cashmanetal.,2009a,2009b). ProprietaryLtd.,USPatentApplication20160038551.
However,fromanherbalproductperspective,wherethesafeand DEA,2008.IntelligenceAlert:SceletiumtortuosuminJamesport.Mo.MicrogramBull.
effective threshold of a pharmaceutical product does not need to be 41(12),106.
Denmark,S.E.,Marcin,L.R.,1997.Asymmetricconstructionofaquaternarycarbon
met, the trials using standardized commercial preparations are quite centerbytandem[4+2]/[3+2]cycloadditionsofnitroalkenes.Thetotalsynthesisof
helpfulinaddressingtheissuesofsafetyandtolerabilityneededforan (-)-mesembrine.J.Org.Chem.62(6),1675–1686.
herbal product. As with all natural product preparations, QA/QC for
Dimpfel,W.,Gericke,N.,Suliman,S.,Dipah,G.N.C.,2016a.Psychophysiologicaleffects
ofZembrin®usingquantitativeEEGsourcedensityincombinationwitheye-tracking
thedeliveryofaconsistentproductwithpredictablebiologicaleffectsis
in60healthysubjects.Adouble-blind,randomized,placebo-controlled,3-armed
aconsiderablechallenge.Anotherissueforthenon-prescriptionuseof studywithparalleldesign.Neurosci.Med.7,114–132.
theseparticularpreparationsisthesignificantpotencyasaserotonin Dimpfel,W.,Schombert,L.,Gericke,N.,2016b.ElectropharmacogramofSceletium
tortuosumextractbasedonspectrallocalfieldpowerinconsciousfreelymovingrats.
reuptake inhibitor. Inappropriate use of the product or use in J.Ethnopharmacol.177,140–147.
combinationwithotherantidepressantsorherbalproductsmightlead Doepke,W.,Sewerin,E.,Trimino,Z.,Julierrez,C.,1981.Isolation,structureand
to serious interactions or serotonin syndrome. If these products ever stereochemistryofanewalkaloidfromCrinumoliganthum.Z.fuerChem.21(10),
358.
seemorewidespreadmarketing,thenitwouldbeaprioritytoaddress Dye,E.,2013.NovelHallucinogenicandPlant-DerivedHighs.〈http://www.nist.gov/
theserealpossibilities. oles/upload/NIST-Novel-Hallucinogens-and-Plant-Derived-Highs-Final.pdf〉
(accessed16.11.03).
Gelas-Mialhe,Y.,Gramain,J.C.,Hajouji,H.,Remuson,R.,1992.Intramolecular
Acknowledgements cyclizationofallylsilylsubstitutedN-acyliminiumions.Accessto1-and2-
azabicyclo[x.y.0]alkanes.Totalsynthesisof(±)-mesembrine.Heterocycles34(1),
37–49.
The author wishes to thank the KGI School of Pharmacy for the Geoghegan,K.,Evans,P.,2013.Doublereductionofcyclicaromaticsulfonamides:
time and resources to complete this review. This research did not synthesisof(+)-mesembrineand(+)-mesembranol.J.Org.Chem.78(7),
3410–3415.
receive any specific grant from funding agencies in the public,
Gerbaulet,M.,1996.RevisionofthegenusSceletiumN.E.Br.(Aizoaceae).Bot.Jahrb.fur
commercial, or not-for-profit sectors. The author has no conflicts of Syst.,Pflanzengesch.undPlanzengeographie118(1),9–24.
interest nor does he have any financial interest in the materials or Gericke,N.,Viljoen,A.M.,2008.Sceletium–areviewupdate.J.Ethnopharmacol.119
(3),653–663.
studiesdiscussedinthisreview.
17

## Page 9

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
Gericke,N.Peter,VanWyk,B.-E.,2001.Pharmaceuticalcompositionscontaining Lesiak,A.D.,Cody,R.B.,Ubukata,M.,Musah,R.A.,2016.Directanalysisinrealtime
mesembrineandrelatedcompounds.AfricanNaturalHealthCC,USPatent highresolutionmassspectrometryasatoolforrapidcharacterizationofmind-
6,288,104. alteringplantmaterialsandrevelationofsupplementadulteration–Thecaseof
Gericke,N.,Harvey,A.,Viljoen,A.,Hofmeyr,D.,2015.Sceletiumextractanduses Kanna.ForensicSci.Int.260,66–73.
thereof.H.L.Hall & SonsLtd.,USPatent8,980,338. Lewis,J.R.,1990.Amaryllidaceaealkaloids.Nat.Prod.Rep.7(6),549–556.
Gericke,N.,Harvey,A.,Viljoen,A.,Hofmeyr,D.,2016.Sceletiumextractanduses Lewis,J.R.,1992.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.9(2),
thereof.H.L.Hall & SonsLtd.,USPatent9,81,220. 183–191.
Gramain,J.C.,Remuson,R.,1985.Cyclizationofallylsilanes.Form.TotalSynth.( Lewis,J.R.,1993.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.10(3),
±)-mesembrine.TetrahedronLett.26(34),4083–4086. 291–299.
Hackett,S.,Livinghouse,T.,1986.Anefficientformalsynthesisofd,l-mesembrineviaa Lewis,J.R.,1994.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.11(3),
β-(methoxy(phenylthio)methylidene)enolateRobinsonannulationsequence.J.Org. 329–332.
Chem.51(9),1629–1631. Lewis,J.R.,1995.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.12(3),
Hammock,B.D.,Inceoglu,A.B.,Jinks,S.L.,2011.Alleviationgdisorderswithcombining 339–345.
agentsthatincreaseepoxgenatedfattyacidsandagentsthatincreasecAMP.The Lewis,J.R.,1996.AmaryllidaceaeandSceletiumAlkaloids.Nat.Prod.Rep.13(2),
RegentsoftheUniversityofCaliforniaOfficeofTechnology,USPatent 171–176.
Application20110230504. Lewis,J.R.,1997.Amaryllidaceaealkaloids.Nat.Prod.Rep.14(3),303–308.
Hartwich,C.,Zwicky,E.,1914.Channa(MesembrianthemumexpansumandM. Lewis,J.R.,1998.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.15(1),
tortuosumL.).Apoth.Ztg.29,925–926,(937-929,949-950,961-922). 107–110.
Harvey,A.,Gericke,N.,Viljoen,A.,2010.Useofpharmaceuticalcompositionscontaining Lewis,J.R.,1999.Miscellaneousalkaloids:amaryllidaceae,Sceletium,muscarine,
mesembrenone.PCTApplicationWO2010106494. imidazole,oxazole,peptideandothermiscellaneousalkaloids.Nat.Prod.Rep.16
Harvey,A.L.,Young,L.C.,Viljoen,A.M.,Gericke,N.P.,2011.Pharmacologicalactionsof (3),389–416.
theSouthAfricanmedicinalandfunctionalfoodplantSceletiumtortuosumandits Lewis,J.R.,2000.Amaryllidaceae,muscarine,imidazole,oxazole,thiazoleandpeptide
principalalkaloids.J.Ethnopharmacol.137(3),1124–1129. alkaloids,othermiscellaneousalkaloids.Nat.Prod.Rep.17(1),57–84.
Herbert,R.B.,Kattah,A.E.,1990.ThebiosynthesisofSceletiumalkaloidsinSceletium Lewis,J.R.,2001.Amaryllidaceae,Sceletium,imidazole,oxazole,thiazole,peptideand
subvelutinumL.Bolus.Tetrahedron46(20),7105–7118. miscellaneousalkaloids(July1998toJune1999).Nat.Prod.Rep.18(1),95–128.
Holford,P.,2002.OralSupplement.Holford & AssociatesLtd.,PCTApplication Lewis,J.R.,2002.Amaryllidaceae,Sceletium,imidazole,oxazole,thiazole,peptideand
WO2002092112. miscellaneousalkaloids.Nat.Prod.Rep.19(2),223–258.
Honda,T.,Arai,H.,Yamamoto,N.,Takahashi,K.,2012.FormalsynthesisofSceletium Lubbe,A.,Khatib,A.,Yuliana,N.D.,Jinap,S.,Verpoorte,R.,2010.CannabinoidCB1
alkaloids,(±)-mesembrineand(±)-mesembranol.Heterocycles84(1),327–331. receptorbindingandacetylcholinesteraseinhibitoryactivityofSceletiumtortuosum
Hoshino,O.,Sawaki,S.,Shimamura,N.,Onodera,A.,Umezawa,B.,1978.Synthesisof( L.International.FoodRes.J.17(2),349–355.
±)-mesembrine.Heterocycles10,61–66. MacKenzie,S.J.,Houslay,M.D.,2000.ActionofrolipramonspecificPDE4cAMP
Hoshino,O.,Sawaki,S.,Shimamura,N.,Onodera,A.,Umezawa,B.,1987.Synthesisof phosphodiesteraseisoformsandonthephosphorylationofcAMP-response-element-
SceletiumandAmaryllidaceaealkaloids,(±)-mesembrineand( bindingprotein(CREB)andp38mitogen-activatedprotein(MAP)kinaseinU937
±)-dihydromaritidine,(±)-epidihydromaritidine,(±)-elwesine,and( monocyticcells.BiochemJ.347(Pt2),571–578.
±)-epielwesine.Chem.Pharm.Bull.35(7),2734–2743. Martin,S.F.,Puckette,T.A.,Colapret,J.A.,1979.Newmethodsforalkaloidsynthesis.
Ilardi,E.A.,Isaacman,M.J.,Qin,Y.-C.,Shelly,S.A.,Zakarian,A.,2009.Consecutive Faciletotalsynthesesof(±)-O-methyljoubertiamineand(±)-mesembrine.J.Org.
sigmatropicrearrangementsintheenantioselectivetotalsynthesisof Chem.44(19),3391–3396.
(-)-joubertinamineand(-)-mesembrine.Tetrahedron65(16),3261–3269. Meyer,G.M.J.,Wink,C.S.D.,Zapp,J.,Maurer,H.H.,2015.GC-MS,LC-MSn,LC-high
Jeffs,P.W.,1981.Sceletiumalkaloids.Alkaloids19.AcademicPress,1–80. resolution-MSn,andNMRstudiesonthemetabolismandtoxicologicaldetectionof
Jeffs,P.W.,Capps,T.M.,1979.IsolationandstructureofanewSceletiumalkaloid mesembrineandmesembrenone,themainalkaloidsofthelegalhigh"Kanna"
containingadihydropyridonering.TetrahedronLett.2,131–132. isolatedfromSceletiumtortuosum.Anal.Bioanal.Chem.407(3),761–778.
Jeffs,P.W.,Hawks,R.L.,Farrier,D.S.,1969.Structureofthemesembranolsandthe Meyers,A.I.,Hanreich,R.,Wanner,K.T.,1985.Anefficientasymmetricsynthesisof
absoluteconfigurationofmesembrineandrelatedalkaloids.J.Am.Chem.Soc.91 (+)-mesembrineandrelatedchiral4,4-disubstitutedcyclohexenones.J.Am.Chem.
(14),3831–3839. Soc.107(25),7776–7778.
Jeffs,P.W.,Ahmann,G.,Campbell,H.F.,Farrier,D.S.,Ganguli,G.,Hawks,R.L.,1970. Michael,J.P.,Howard,A.S.,Katz,R.B.,Zwane,M.I.,1992.Formalsynthesisof(
AlkaloidsofSceletiumspecies.III.StructuresoffournewalkaloidsfromS.strictum. ±)-mesembrineand(±)-dihydromaritidine.TetrahedronLett.33(40),6023–6024.
J.Org.Chem.35(10),3512–3518. Mori,M.,Kuroda,S.,Zhang,C.S.,Sato,Y.,1997a.Totalsynthesesof(-)-mesembrane
Jeffs,P.W.,Archie,W.C.,Hawks,R.L.,Farrier,D.S.,1971.Sceletiumalkaloids.IV. and(-)-mesembrineviapalladium-catalyzedenantioselectiveallylicsubstitutionand
Biosynthesisofmesembrineandrelatedalkaloids.Aminoacidprecursors.J.Am. zirconium-promotedcyclization.J.Org.Chem.62(10),3263–3270.
Chem.Soc.93(15),3752–3758. Mori,M.,Kuroda,S.,Zhang,C.S.,Sato,Y.,Nishimata,T.,1997b.Synthesisof
Jeffs,P.W.,Karle,J.M.,Martin,N.H.,1978.Sceletiumalkaloids.Part8.Cinnamicacid (-)-mesembrineusingtransitionmetal-promotedC-Cbondformingreaction.
intermediatesasprecursorstomesembrineandsomeobservationsonthelatestages TennenYukiKagobutsuToronkaiKoenYoshishu39th,19-24.
inthebiosynthesisofthemesembrinealkaloids.Phytochemistry17(4),719–728. Murbach,T.S.,Hirka,G.,Szakonyine,I.P.,Gericke,N.,Endres,J.R.,2014.A
Jeffs,P.W.,Capps,T.M.,Redfearn,R.,1982.Sceletiumalkaloids.Structuresoffivenew toxicologicalsafetyassessmentofastandardizedextractofSceletiumtortuosum
basesfromSceletiumnamaquense.J.Org.Chem.47(19),3611–3617. (Zembrin®)inrats.FoodChem.Toxicol.74,190–199.
Jeffs,P.W.,Redfearn,R.,Wolfram,J.,1983.Totalsynthesesof(±)-mesembrine,( Nell,H.,Siebert,M.,Chellan,P.,Gericke,N.,2013.Arandomized,double-blind,parallel-
±)-joubertinamine,and(±)-N-demethylmesembrenone.J.Org.Chem.48(21), group,placebo-controlledtrialofextractSceletiumtortuosum(Zembrin®)inhealthy
3861–3863. adults.J.Altern.Complement.Med.(NewY.,N.Y.)19(11),898–904.
Jin,Z.,2003.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.20(6),606–614. Nemoto,H.,Tanabe,T.,Fukumoto,K.,1994.Anasymmetricsynthesisofbenzylic
Jin,Z.,2005.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.22(1),111–126. quaternarycarboncenters.Aformaltotalsynthesisof(-)-mesembrine.Tetrahedron
Jin,Z.,2007.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.24(4),886–905. Lett.35(35),6499–6502.
Jin,Z.,2009.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.26(3),363–381. Nemoto,H.,Tanabe,T.,Fukumoto,K.,1995.Ahighlyenantiocontrolledstrategyforthe
Jin,Z.,2011.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.28(6), synthesisofbenzylicquaternarycarboncenters.Aformaltotalsynthesisof
1126–1142. (-)-mesembrine.J.Org.Chem.60(21),6785–6790.
Jin,Z.,2013.AmaryllidaceaeandSceletiumalkaloids.Nat.Prod.Rep.30(6),849–868. Nieuwenhuis,J.J.,Strelow,F.,Strauss,H.F.,Wiechers,A.,1981.4R)-(-)-O-
Jin,Z.,Li,Z.,Huang,R.,2002.Muscarine,imidazole,oxazole,thiazole,Amaryllidaceae methyljoubertiamineandO-methyldihydrojoubertiamine,twominoralkaloidsfrom
andSceletiumalkaloids.Nat.Prod.Rep.19(4),454–476. SceletiumsubvelutiumL.Bolus.J.Chem.Soc.PerkinTrans.1:Org.Bio-Org.Chem.
Kielian,T.,2014.Compositionsandmethodsforthetreatmentofjuvenileneuronal 1,284–286.
ceroidlipofuscinosisandrelateddisorders.BoardofRegentsoftheUniversityof Nunokawa,S.,Minamisawa,M.,Nakano,K.,Ichikawa,Y.,Kotsuki,H.,2015.Asymmetric
Nebraska,USPatantApplication20140121166. michaeladditionreactionofα-aryl-substitutedlactamscatalyzedbychiral
Kochhar,K.S.,Pinnick,H.W.,1983.Ashortsynthesisof(±)-mesembrine.Tetrahedron quaternaryammoniumsaltsderivedfromcinchonaalkaloids:anewshortsynthesis
Lett.24(44),4785–4788. of(+)-mesembrine.Synlett26(16),2301–2305.
Kosugi,H.,Miura,Y.,Kanna,H.,Uda,H.,1993.Anewroutetoenantiomericallypure Ohishi,T.,Kugita,H.,1968.Synthesisofdl-mesembrineanditstransisomer.
4,4-disubstitutedcyclohex-2-en-1-ones:asymmetricsynthesisof(+)-mesembrine. TetrahedronLett.52,5445–5448.
Tetrahedron.:Asymmetry4(7),1409–1412. Ohishi,T.,Kugita,H.,1970.Synthesisofdl-mesembrineanditstransisomer.Chem.
Kulkarni,M.G.,Rasne,R.M.,Davawala,S.I.,Doke,A.K.,2002.Allylvinylethersvia Pharm.Bull.18(2),299–303.
Wittigolefination:ashortandefficientsynthesisof(±)-mesembrine.Tetrahedron Otani,G.,Yamada,S.,1973.Stereochemicalstudies.XXVII.Totalsynthesisof
Lett.43(12),2297–2298. (+)-mesembrinewithasymmetricsynthesisusingprolinederivative.Chem.Pharm.
Langlois,M.,Guillonneau,C.,Meingan,J.,Maillard,J.,1971.3-Arylpyrrolidines.II. Bull.21(10),2130–2135.
Synth.mesembrinecrinineAnalogsTetrahedron27(22),5641–5652. Ozaki,T.,Kobayashi,Y.,2015.Synthesisof(-)-mesembrineusingthequaternarycarbon-
Langlois,M.,Delaunay,P.,Garcia,G.,Roussillon,J.-L.R.,Maillard,J.,Morin,R.M., constructingallylicsubstitution.Org.Chem.Front.2(4),328–335.
Chantal,M.,1972.Researchin10seriesof3-arylpyrrolidinesIII.Preparationof Parkinson,C.J.,Pinhey,J.T.,1991.Useoftheelectrophilicarylationreactionofaryllead
derivativesofbenzo(e)indoleandindano(1,2b)pyrroleChimietherapeutique7, triacetatesinsynthesesof(±)-O-methyljoubertiamineand(±)-mesembrine.J.
450–458. Chem.Soc.,PerkinTrans.1:Org.Bio-Org.Chem.5,1053–1057.
Lefebvre,R.A.,DeMaeyer,J.H.,2013.Combinationtherapy.ShireAG,USPatent Patnala,S.,Kanfer,I.,2008.Acapillaryzoneelectrophoresismethodfortheassayand
Application20130045988. qualitycontrolofmesembrineinSceletiumtablets.J.Pharm.Biomed.Anal.48(2),
18

## Page 10

J.L.Krstenansky Journal of Ethnopharmacology 195 (2017) 10–19
440–446. Shono,T.,Terauchi,J.,Matsumura,Y.,1989.Electoorganicchemistry.122.Anewfacile
Patnala,S.,Kanfer,I.,2010.HPLCanalysisofmesembrine-typealkaloidsinSceletium methodforconstructionofβ-arylpyrrolidineringsanditsapplicationtothe
plantmaterialusedasanAfricantraditional.Med.J.Pharm.Pharm.Sci.13(4), synthesisof(±)-mesembrine.Chem.Lett.11,1963–1966.
558–570. Smith,M.T.,Crouch,N.R.,Gericke,N.,Hirst,M.,1996.Psychoactiveconstituentsofthe
Patnala,S.,Kanfer,I.,2013.Chemotaxonomicstudiesofmesembrine-typealkaloidsin genusSceletiumN.E.Br.andothermesembryanthemaceae:areview.J.
Sceletiumplantspecies.SouthAfr.J.Sci.109(3/4),1–5. Ethnopharmacol.50(3),119–130.
Paul,T.,Malachowski,W.P.,Lee,J.,2006.Theenantioselectivebirch-copesequencefor Smith,M.T.,Field,C.R.,Crouch,N.R.,Hirst,M.,1998.Thedistributionofmesembrine
thesynthesisofcarbocyclicquaternarystereocenters.Applicationtothesynthesisof alkaloidsinselectedtaxaoftheMesembryanthemaceaeandtheirmodificationinthe
(+)-mesembrine.Org.Lett.8(18),4007–4010. Sceletiumderived"kougoed".Pharm.Biol.36(3),173–179.
Pigni,N.B.,Rios-Ruiz,S.,Luque,F.J.,Viladomat,F.,Codina,C.,Bastida,J.,2013.Wild Spittler,M.,Lutsenko,K.,Czekelius,C.,2016.Totalsynthesisof(+)-mesembrine
daffodilsofthesectionGanymedesfromtheIberianPeninsulaasasourceof applyingasymmetricgoldcatalysis.J.Org.Chem.81(14),6100–6105.
mesembranealkaloids.Phytochem.95,384–393. Stevens,R.V.,Lesko,P.M.,Lapalme,R.,1975.Generalmethodsofalkaloidsynthesis.XI.
Popelak,A.,Lettenbauer,G.,1962.9-phenyloctahydroindolecompoundsandprocessof TotalsynthesisoftheSceletiumalkaloidA-4andanimprovedsynthesisof
makingsame.BoehringerSoehneGmbh,(USPatent3,028,394). (+-)-mesembrine.J.Org.Chem.40(24),3495–3498.
Popelak,A.,Lettenbauer,G.,1967.Chapter11Mesembrinealkaloids.In:Manske, Swart,A.C.,Smith,C.,2016.Modulationofglucocorticoid,mineralocorticoidand
R.H.F.(Ed.),TheAlkaloids:ChemistryandPhysiology9.AcademicPress,NewYork, androgenproductioninH295cellsbyTrimesemine™,amesembrine-richSceletium
467–482. extract.J.Ethnopharmacol.177,35–45.
Popelak,A.,Haack,E.,Lettenbauer,G.,Spingler,H.,1960a.Constitutionofmesembrine. Taber,D.F.,Neubert,T.D.,2001.Enantioselectiveconstructionofcyclicquaternary
Naturwissenschaften47,156. centers:(-)-mesembrine.J.Org.Chem.66(1),143–147.
Popelak,A.,Lettenbauer,G.,Haack,E.,Spingler,H.,1960b.Structureofmesembrine Taber,D.F.,He,Y.,2005.Openingofaryl-substitutedepoxidestoformquaternary
andmesembrenine.Naturwissenschaften47,231–232. stereogeniccenters:synthesisof(-)-mesembrine.J.Org.Chem.70(19),7711–7714.
Rajagopalan,P.,1997.Anewsynthesisof(±)-mesembrineinvolvingtheintramolecular Takano,S.,Imamura,Y.,Ogasawara,K.,1981a.Anothersynthesisof(±)-mesembrine
nucleophilicattackofanallylaniononacarbonylfunctionofanimide.Tetrahedron usingasymmetricstartingmaterial.Chem.Lett.10,1385–1386.
Lett.38(11),1893–1894. Takano,S.,Imamura,Y.,Ogasawara,K.,1981b.Enantioselectivesynthesisofnatural
Rigby,J.H.,Dong,W.,2000.[4+1]CycloadditionofBis(alkylthio)carbeneswithvinyl mesembrineusing(D)-mannitolasachiraltemplate,amodelstudyforthe
Isocyanates.Totalsynthesisof(±)-mesembrine.Org.Lett.2(12),1673–1675. enantioselectivesynthesisoftheAmaryllidaceaealkaloids.TetrahedronLett.22
Rimington,C.,Roets,G.C.S.,1937.Theisolationofthealkaloidalconstituentofthedrug (45),4479–4482.
"channa"or"kougoed"(MesembryanthemumanatomicumandM.tortuosum). Takano,S.,Samizu,K.,Ogasawara,K.,1990.Enantiospecificconstructionofquaternary
OnderstepoortJ.Vet.Res.9,187–191. carboncenterviaintramolecular1,3-dipolarcycloaddition.Anewroutetonatural
Roe,C.,Sandoe,E.J.,Stephenson,G.R.,Anson,C.E.,2008.Stereoselectivityinthe (-)-mesembrinefrom(S)-O-benzylglycidol.Chem.Lett.7,1239–1242.
organoiron-mediatedsynthesisof(±)-mesembrine.TetrahedronLett.49(4), Tavoulari,S.,Forrest,L.R.,Rudnick,G.,2009.Fluoxetine(Prozac®)bindingtoserotonin
650–653. transporterismodulatedbychlorideandconformationalchanges.J.Neurosci.29
Roscher,J.,Posch,T.N.,Puetz,M.,Huhn,C.,2012.Forensicanalysisofmesembrine (30),9635–9643.
alkaloidsinSceletiumtortuosumbynonaqueouscapillaryelectrophoresismass Terburg,D.,Syal,S.,Rosenberger,L.A.,Heany,S.,Phillips,N.,Gericke,N.,Stein,D.J.,
spectrometry.Electrophoresis33(11),1567–1570. vanHonk,J.,2013.AcuteeffectsofSceletiumtortuosum(Zembrin®),adual5-HT
Sandager,M.,Nielsen,N.D.,Stafford,G.I.,vanStaden,J.,Jager,A.K.,2005.Alkaloids reuptakeandPDE4inhibitor,inthehumanamygdalaanditsconnectiontothe
fromBoophonedistichawithaffinitytotheserotonintransporterinratbrain.J. hypothalamus.Neuropsychopharmacology38(13),2708–2716.
Ethnopharmacol.98(3),367–370. ThePlantList,2013.Version1.1〈http://www.theplantlist.org/〉(accessed16.11.04).
Schell,R.,2014.Sceletiumtortuosumandmesembrine:apotentialalternativetreatment Toniolo,C.,Nicoletti,M.,Maggi,F.,Venditti,A.,2014.HPTLCdeterminationofchemical
fordepression.ScrippsSeniorTheses,Paper375. compositionvariabilityinrawmaterialsusedinbotanicals.Nat.Prod.Res.28(2),
Shamma,M.,Rodriguez,H.R.,1965.Totalsynthesisof(±)-mesembrine.Tetrahedron 119–126.
Lett.52,4847–4851. Yamada,S.,Otani,G.,1971.Totalsynthesisof(+)-mesembrinebyasymmetricsynthesis
Shamma,M.,Rodriguez,H.R.,1968.Synthesisof(+-)-mesembrine.Tetrahedron24 withaminoacid.TetrahedronLett.16,1133–1136.
(22),6583–6589. Yokomatsu,T.,Iwasawa,H.,Shibuya,S.,1992.Highlyenantioselectivecreationof
Shikanga,E.A.,Viljoen,A.,Combrinck,S.,Marston,A.,2011.IsolationofSceletium quaternarycarbonsinahalolactonizationofbis-γ,δ-unsaturatedcarboxylicimides
alkaloidsbyhigh-speedcountercurrentchromatography.Phytochem.Lett.4(2), derivedfromacamphorsultam:enantioselectivesynthesisof(+)-mesembrine.
190–193. TetrahedronLett.33(46),6999–7002.
Shikanga,E.A.,Kamatou,G.P.P.,Chen,W.,Combrinck,S.,Viljoen,A.M.,2012a. Yoshimitsu,T.,Ogasawara,K.,1996.Anewsynthesisof(-)-mesembrineemploying
ValidatedRP-UHPLCPDAandGC-MSmethodsfortheanalysisofpsychoactive SharplessADreactionandnewradical-initiatedreaction.Heterocycles42(1),
alkaloidsinSceletiumtortuosum.SouthAfr.J.Bot.82,99–107. 135–139.
Shikanga,E.A.,Vermaak,I.,Viljoen,A.M.,2012b.AnHPTLC-densitometrymethodfor Zhang,Q.,Xie,J.,Yang,X.,Xie,J.,Zhou,Q.,2012.Iridium-catalyzedasymmetric
thequantificationofpharmacologicallyactivealkaloidsinSceletiumtortuosumraw hydrogenationofα-substitutedα,β-unsaturatedacyclicketones:enantioselective
materialandproducts.J.PlanarChromatogr.Mod.TLC25(4),283–289. totalsynthesisof(-)-mesembrine.Org.Lett.14(24),6158–6161.
Shikanga,E.A.,Viljoen,A.M.,Combrinck,S.,Marston,A.,Gericke,N.,2012c.The Zhao,Y.,Zhao,D.,Zhou,Y.,Zhang,H.,2009.Formalsynthesisof(±)-Mesembrine.
chemotypicvariationofSceletiumtortuosumalkaloidsandcommercialproduct YunnanDaxueXuebao,ZiranKexueban31(4),396–399.
formulations.Biochem.Syst.Ecol.44,364–373. Zhao,Y.,Zhou,Y.,Du,F.,Liang,L.,Zhang,H.,2010.Reviewoftotalsynthesisof
Shikanga,E.A.,Viljoen,A.M.,Vermaak,I.,Combrinck,S.,2013.Anovelapproachin mesembrine.YoujiHuaxue30(1),47–59.
herbalqualitycontrolusinghyperspectralimaging:discriminatingbetween Zwicky,E.,1915.Channa,arootusedbytheHottentots.Vierteljahrsschr.Nat.Ges.Zur.
SceletiumtortuosumandSceletiumcrassicaule.Phytochem.Anal.24(6),550–555. 58,372–429,(alsoinZentrBiochemBiophys318,470).
19

